San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...

Berkeley, California-based Eko Devices has received FDA clearance for Duo, a smart heart monitor that is a combination of a digital stethoscope and portable electrocardiogram. Duo is intended as a ...

SAN FRANCISCO, March 3, 2025 /PRNewswire/ — Eko Health, a leader in artificial intelligence (AI) for the early detection of heart and lung diseases, today announced the publication of a peer-reviewed ...

HOBOKEN, N.J. and OAKLAND, Calif., July 14, 2021 /PRNewswire/ — Health Recovery Solutions, a leading provider of telehealth and remote patient monitoring solutions, today announced a partnership with ...

Eko, a San Francisco-based startup developing artificial intelligence for heart disease screening, telehealth and remote patient monitoring, closed a $65 million Series C funding round, according to a ...

Heart failure with reduced ejection fraction (HFrEF) happens when the heart’s left ventricular ejection fraction (LVEF) is 40% or less, a sign of a weak heart pump. The problem is that this sign of ...

Heart disease remains the leading cause of death in the U.S. and around the world, but rapid, early screening options are still few and far between. Digital stethoscope developer Eko hopes to change ...

Dr. Demilade Adedinsewo and nurse review electrocardiogram (EKG) results on a monitor while the patient is lying down. Group 1: 100 women already scheduled for an echocardiogram (the best test to ...

Eko’s smart stethoscopes have been used by U.S. physicians to automatically detect signs of atrial fibrillation and heart murmurs since its first FDA clearance arrived in 2020. A new regulatory OK ...

San Francisco, July 25, 2019 (GLOBE NEWSWIRE) -- Eko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced Eko Home, a ...

Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the ...